EuroEyes International Eye Clinic Limited (1846.HK)

HKD 3.95

(1.28%)

Market Cap (In HKD)

1.3 Billion

Revenue (In HKD)

714.28 Million

Net Income (In HKD)

131.24 Million

Avg. Volume

88.72 Thousand

Currency
HKD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.74-5.82
PE
-
EPS
-
Beta Value
1.218
ISIN
KYG3224D1088
CUSIP
G3224D108
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Dr. Jörn Slot Jörgensen
Employee Count
-
Website
https://www.euroeyes.hk
Ipo Date
2019-10-15
Details
EuroEyes International Eye Clinic Limited provides vision correction services in Germany, Denmark, and the People's Republic of China. The company offers refractive laser surgery, which include ReLEx SMILE and FemtoLASIK; phakic lens (ICL) surgery; lens exchange surgery comprising the monofocal and trifocal lens exchange surgery; and PRK/LASEK and ICRS implantation services. Its correction services are used for the treatment of myopia, high myopia, presbyopia, and cataract. The company serves mid-to-high income level customers, who primarily seek surgery to treat their myopia; and above 45 years of age, who primarily seek surgery to treat their presbyopia or cataract. It operates consultation centers and clinics for eye treatment and LASIK centers; and sells pharmaceutical products. The company is also involved in the trading of eye clinic equipment and lenses; and ophthalmic equipment renting and spaces operating activities. EuroEyes International Eye Clinic Limited was founded in 1993 and is headquartered in Hamburg, Germany.